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Nature of soft tissue calcification in uremia. The chemical and
crystalline composition of metastatic calcification was studied in
21 uremic patients. Nonvisceral calcification has a calcium!
magnesium/phosphorus (Ca: Mg: P) molar ratio of 30/1/18 and
an apatitic x-ray diffraction pattern. The molar ratio of Ca/Mg/P
in 33 tissue specimens (heart, lung and skeletal muscle) with
calcification obtained from 19 uremic patients was 4.9/1/4.6,
and x-ray diffraction showed only an amorphous pattern.
Following incineration at 500°C, the diffraction pattern of
magnesium whitlockite (CaMg)3(PO4)2 was found. This study
demonstrates two distinct forms of calcium phosphate deposits
in uremic patients. Nonvisceral and arterial calcification are
hydroxyapatite. Calcification in heart, lung and skeletal muscle
is an amorphous or microcrystalline compound composed of
Ca/Mg/P in a constant molar ratio and is somewhat like whit-
lockite. The different tissue response incited by these two com-
pounds is probably related to the larger crystal size found in
nonvisceral calcification.
Nature des calcifications des tissus mous au cours de l'urémie.
La composition chimique et cristalline des calcifications méta-
statiques a été étudiée chez 21 malades atteints d'urémie. Les
calcifications non viscérales ont un rapport molaire Ca: Mg: P
de 30:1:18 et un spectre apatitique de diffraction des rayons X.
Le rapport molaire Ca: Mg: P dans 33 échantillons de tissus
(cceur, poumon et muscle squelettique) calcifiés provenant de
19 malades urémiques est de 4,9:1:4,6 et la diffraction des
rayons X montre une structure amorphe. Aprés incineration a
500°C Ic spectre de diffraction du (Ca, Mg)3(P04)2 est obtenu.
Ce travail met en evidence deux formes distinctes de dépôts de
phosphate de calcium chez les malades urémiques. Les calcifica-
tions extra-viscérales et artCrielles sont de l'hydroxyapatite. Les
calcifications du ceur du poumon et du muscle squelettique sont
un compose amorphe ou microcristallin de calcium-magnesium-
phosphate dans un rapport molaire constant et semblable au
(Ca, Mg)3(P04)2. Les differences de Ia rCponse tissulaire induite
par les deux types de composes est probablement liée It Ia taille
plus grande des cristaux trouvCs dans les calcifications non
viscérales.
Although ocular, arterial, periarticular and cutaneous
calcification in uremia have received the most attention,
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Mulligan clearly showed that heart, lung, stomach and
kidney calcifications also occur [1]. With the advent of
treatment by hemodialysis, soft tissue calcification has been
noted with increased frequency and has been associated
with a number of clinical symptoms and findings including
pruritis [2], respiratory insufficiency [3], complete heart
block [4], low cardiac output states [4], arthritis [5] and
vascular insufficiency [6].
Most authors have assumed that all tissue calcification
in uremic patients is hydroxyapatite [7]. However, in
reviewing material obtained at autopsy from patients with
chronic renal failure, it was noted that different forms of
calcification occur in regards to the gross and histological
features suggesting that the crystalline structure may not
be uniform.
We have undertaken to characterize the anatomical,
chemical and crystalline nature of visceral and nonvisceral
calcification, to attempt to correlate visceral calcification
with clinical evidence of hyperparathyroidism and para-
thyroid weight, and to determine if muscle calcium con-
centration can be used as an index to assess whether
pulmonary and myocardial calcification is present.
Methods
Patients. Tissue specimens were obtained from 35 pa-
tients with end-stage renal disease and 11 nonuremic
controls as soon as possible after their deaths; the speci-
mens were kept frozen until analyzed. Twenty-seven of the
uremic patients had been maintained with hemodialysis for
a mean period of 23 months. Dialysis was performed with
a standard bath containing a magnesium concentration of
1.3 mEq/liter. In approximately one-half of the patients,
dialysis was performed using a 3.5 mEq/liter calcium bath,
whereas in the other group dialysis was performed with
both a 2 and 3.5 mEq/liter calcium bath at different times
during the course of dialysis. Eight patients had not under-
gone dialysis or had been dialyzed for less than three
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months. All dialyzed patients received treatment with
phosphate-binding gels in an attempt to keep serum phos-
phorus concentration below 6 mg/lOO ml, although this
was not always accomplished.
Control tissue specimens were obtained from subjects of
similar age and sex who had no history of renal disease.
The majority were individuals who had not been hospi-
talized and whose sudden deaths resulted from automobile
accidents.
Sections of myocardium were routinely obtained from
the left ventricle and lung section from random areas.
Regions that were visibly calcified were avoided when
possible, with the exception of one dense placque of calcifi-
cation present in a diaphragm which was obtained in an
attempt to obtain as pure a compound as possible (Fig. 1).
Nonvisceral calcification was removed from two patients,
one at surgery (periarticular calcification) and the second
from the sacral area at the time of autopsy (Fig. 2). A seg-
ment of calcified femoral artery was also removed for
diffraction studies. The parathyroid glands were dissected
free, weighed and sectioned for histology.
Throughout the paper visceral calcification will be used
to denote muscle, lung or heart calcium deposits, or a combi-
nation of the three, and nonvisceral calcification will refer
to the discrete calcium deposits that occur in the sub-
cutaneous tissue and around tendons.
Tissue preparation. Approximately one g of each sampleFig. 1. Calcium phosphate deposits on a piece of diaphragm. The
white areas are the calcium deposits and the dark regions are (heart, lung and skeletal muscle) was cut into small pieces
uninvolved diaphragm, and dried for 16 hours at 130 °C. The tissue was then ground
Fig. 2. Large cystic mass removed from
the sacral area. The wall of the cyst is
thick fibrous tissue. Inside, the calcium
phosphate deposit is in a semisolid
form.
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to a fine powder and extracted four times with 2 ml of
ether petroleum ether (1/I, v/v). The tissue was then redried
at 130° for one hour and reweighed. The dry, defatted
tissue was digested by boiling in 1 ml of nitric acid for one
hour. The resulting clear liquid was diluted to 25 ml with
deionized water.
Material from nonvisceral calcification (Fig. 2) was pre-
pared by lancing the cystic structure with a scalpel and
allowing the gritty yellowish liquid to dry at room tempera-
ture. This material, as well as a sample of the diaphragm
(Fig. 1), was ignited at 550 °C and dissolved in 2 N HCI for
analysis.
Chemical analysis. Calcium and magnesium concentra-
tions were determined with an atomic absorption spectro-
photometer (Perkin-Elmer 290B) operated according to
manufacturer's specifications. Stock standards contained
approximately the same concentrations of Ca, Mg, Na, K,
P04 and nitric acid as the tissue digests. Stock standards
and tissue digests were diluted to an appropriate volume
with lanthanum chloride (1 % La) for Ca determinations
and with deionized water for Mg determinations. Phos-
phorus was determined by the American Monitor method,
an automated modification from Fiske and Subbarow [8].
Tissue phosphorus content reported in the present study
represents both organic and inorganic phosphotus. A rough
approximation of inorganic phosphorus was made in tis-
sues with high calcium content by subtracting the mean
phosphorus concentration found in tissues with normal
calcium levels. It is assumed that all of the excess tissue
phosphorus is in an inorganic state and is part of the
calcium phosphate deposit.
X-ray diffraction analysis. Ten specimens of heart and
lung from six patients with Ca contents above the control
range, material from the diaphragm and nonvisceral and
arterial calcification were studied by x-ray diffraction. The
specimens were dried at room temperature or heated at
130°, 200°, 500° and 900 °C in a muffle furnace, or both.
The dried tissues were ground to a fine powder and mounted
on a glass slide for diffraction studies. Powder x-ray dif-
fraction studies were performed with an x-ray diffracto-
meter unit (Philips Norelco) at the University of Colorado
Department of Geological Science Laboratory in Boulder,
Colorado. The 2(9 diffraction range covered was 12° to 60°
at a scanning speed of 1 °/min. Patterns were interpreted by
comparing them with the American Society of Testing
Materials (ASTM) index cards.
Infrared absorption analysis. About one mg of the pow-
dered sample was mixed intimately with 300mg of KBr
(infrared grade) and pelletized under vacuum at 20,000 '.
The pellets were analyzed using a grating spectrophoto-
meter (Perkin-Elmer 337 IR), ranges 4,000 to 400 cm;
normal slit; scanning speed, 8 minutes (or 30 mm for
slow scan) for range 4,000 to 1,200cm' or 1,300 to
400 cm1.
Results
Histology and anatomy. Upon both gross and histological
examination, there were marked diffeiences between vis-
ceral (heart, lung, muscle) and nonvisceral (periarticular
and subcutaneous) calcification (Fig. I and 2). Visceral
calcification, when visible on gross examination, is a
whitish solid material frequently deposited as small nodules
throughout the myocardium and lung. The solid nature of
a large deposit of this material obtained from a diaphragm
is shown in Fig. 1. On histological examination there is
only a mild fibrotic response. In contrast, nonvisceral
calcification is present in a liquid to semisolid form and
evokes a severe fibrotic reaction which results in encapsula-
tion of the material (Fig. 2). All parathyroid glands showed
some degree of hypercellulaiity. The combined weights of
the four glands obtained from each of 18 patients ranged
from 200 to 7,000 mg.
Chemicalanalysis. Eighty-five tissue specimens consisting
of heart, lung and skeletal muscle were studied in the 35
uremic patients. Thirty-three tissue specimens in 19 pa-
tients had Ca concentrations above the normal range in
association with increased P and Mg concentrations. To
determine if the ratio of these three ions was constant in
the various tissues, a correlation coefficient was calculated.
Excess Ca, Mg and P were approximated by subtracting
the mean control values of these elements found in normal
subject tissues from the measured values in uremic tissues.
The correlation coefficient for Ca/Mg was 0.991 and for
Mg/P was 0.994 (Fig. 3 and 4).
Table 1. Chemical composition of tissues with apatitic diffraction
patterns
Ca
mmoles
Mg P
1kgof dry weight
Nonvisceral calcification
specimen 1 8,021 245 3,807
specimen 2 5,548 183 3,386
Arterial calcification 4,660 174 3,199
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Fig. 3. Relationship between magnesium and phosphorus content
in visceral calcification. P=4.6 Mg+88; r=0.994.
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Fig. 5. X-ray diffraction pattern of visceral calcification. A) Vis-
ceral calcification (diaphragm) untreated and incinerated at
200°C. B) Visceral calcification (heart) incinerated at 500°C.
C) Visceral calcification (heart) incinerated at 900°C. D) Vis-
ceral calcification (lung) incinerated at 900°C.
In an attempt to further characterize the chemical com-
position of this material, a relatively pure sample (Fig. 1)
of visceral calcification was analyzed and found to have a
similar molar ratio (Ca 5.7/Mg 1/P 3.8) as found in the 33
Fig. 6. X-ray diffraction pattern of bone and nonvisceral calcifica-
tion. A) Untreated bone. B) Untreated nonvisceral calcification.
C) Nonvisceral calcification incinerated at 550°C. D) Non-
visceral calcification incinerated at 900°C.
tissues from the 19 patients. Analysis of nonvisceral calcifi-
cation (two patients) and arterial calcification (one patient)
is shown in Table 1. The molar ratio of nonvisceral calcifi-
cation is similar to that found in uremic bone (33/1/19).
Diffraction studies. Representative examples of diffrac-
tion patterns obtained on visceral calcification are shown
in Fig. 5. All tissues studied untreated or heated at 200 °C
or less demonstrated only a low, broad diffraction pattern
consistent with an amorphous material or one of very small
crystals whose dimensions would not give rise to discernible
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visceral calcuication. P= 4.96 Mg+ 77; r= 0.991.
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x-ray diffraction peaks (Fig. 5 A). However igniting at
500° C to 900° C resulted in the development of the major
diffraction peaks of whitlockite (Fig. 5, B, C, D). The whit-
lockite peaks are shifted in the direction of magnesium
whitlockite (Ca Mg)3 (P04)2 and lie closer to Frondel's
standard (ASTM +13—404) than to pure whitlockite
(fi-tricalcium phosphate) (ASTM + 9—169).
Diffraction studies on untreated nonvisceral calcification
(Fig. 6B) revealed hydroxyapatite and had a pattern similar
to that obtained in untreated bone (Fig. 6A) suggesting
similar crystal size. With ignition to 500° and 900°, the
peaks became sharper (Fig. 6, C, D).
Spectroscopic analysis. A difference in the infrared ab-
sorption spectra of the two types of calcification (visceral
and nonvisceral) was also observed (Fig. 7). The JR spec-
trum of nonvisceral calcification gave absorption peaks
corresponding to vibration modes of the OH, P04 and CO3
groups; these peaks identify this material as a carbonate-
containing apatite [9]. The IR spectra of visceral calcifica-
tions gave broad bands suggesting the presence of OH and
P04 groups but no C03; and the bands resemble synthetic
(Ca Mg)3 P04)2 [10].
Correlation between heart, lung and muscle calcium
content. Since findings of x-ray diffraction studies and
chemical analysis showed that muscle, heart and pulmonary
calcification are similar compounds, the Ca content of
these three tissues was compared in the 23 patients where
muscle was available (Table 2). The uremic patients were
separated according to the Ca concentration in muscle.
Group I patients had muscle Ca concentrations within the
control range and group 2 patients had muscle Ca concen-
trations above the control range. One patient in group I
was found to have an increased myocardial Ca concentra-
tion and two patients in this group had elevated pulmonary
Ca concentrations as compared to the control values. In
contrast, all but one patient with increased muscle Ca con-
centrations (group 2) had elevated pulmonary Ca con-
centrations. In addition, five out of seven patients with
2000 1500
Frequency, cm'
Fig.7. Infrared spectra of visceral calcification (A) and nonvisceral
calcification (B). The vibration mode of CO3 is present only in the
nonvisceral calcification.
Table 2. Tissue calcium concentration, mmoles/kg of fat-free dry
solidsa
Muscle Heart Lung
Group 1
5 5 9
6 5 14
6 82 18
7 14 261
8 12 18
8 28 32
8 10 26
8 22 31
9 12 24
10 10 48
Mean 20 48
13
14
14
15
17
42
44
46
46
50
70
90
139
Group 2
12
10
15
15
40
—
515
9
32
575
369
14
716
25
50
469
100
1,164
424
533
496
627
279
114
100
1,358
Mean 194 441
Mean 6.3
Normal
10.6 18.6
SD 2.6 5.4 6.2
The F values of group I for both heart and lung as compared
to those of the normal subjects were not significant. The
F value for heart as compared to that of normal subjects was
<0.025; the F value for lung as compared with that of the
normal subjects was <0.0025.
muscle Ca concentrations above 40 mmoles/kg of fat-free
dry solids had elevated myocardial Ca concentrations as
compared to controls.
Correlation between tissue calcium content and para-
thyroid weight. There was no statistical correlation between
Ca content of heart, lung and muscle and parathyroid
weight (Fig. 8). In addition, neither presence nor degree of
calcification could be correlated with radiographic evidence
of hyperparathyroidism in this group of patients.
Discussion
Our study shows two distinct forms of calcification in
patients with chronic renal failure. Not only are these
compounds unlike with regard to their chemical and diffrac-
tion characteristics, but they also incite different tissue
reactions. Visceral calcification is an amorphous (Ca Mg)3
B
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tion is a Ca/Mg/P compound, possibly micrornicrocrystal-
unities of magnesium whitlockite [14].
Whitlockite was first described by Frondel in minerals
obtained from the Palermo quarry, near North Groton,
New Hampshire [15]. In its pure form it is fl-tricalcium
phosphate, but all natural whitlockite, mineral and bio-
logical, contains Mg [16, 17]. Whitlockite has been found in
the abdominal aorta, appendix and renal and salivary
calculi [18, 19], as well as in bone following incineration at
700° C or greater [20]. Gatter and McCarty studied discrete
calcium deposits obtained from 86 patients [21]. Whit-
lockite was found in only four patients and all had renal
failure.
.
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The development of two distinct calcium phosphate
Fig. 8. Comparison between parathyroid weight (4 glands/patient) compounds may be a result of local tissue factors as well
and tissue Ca content. Open circles represent heart, closed circles
lung, and triangles skeletal muscle Ca concentrations. FFDS=
fat-free dry solids.
as the Ca/Mg/P product present in the uremic patient's
serum. Since Mg has been shown by chemical and diffrac-
. . .tion techniques to be an integral part of visceral calcifica-
tion, it would appear that the increased serum and total
(P04)2. Nonvisceral and arterial calcifications [11] are body Mg concentrations present in uremic patients [22]
hydroxyapatite. The Ca/Mg/P molar ratio and x-ray diffrac- may play an important role in the formation and retention
tion pattern of nonvisceral calcification is almost identical of visceral calcification. In synthetic systems Mg has been
to that of uremic bone. Although these two tissues had shown to disturb crystallization of apatite and stabilize the
similar crystal size, it seems likely that the size of the amorphous phase of calcium phosphate deposits [14].
hydroxyapatite crystal may vary under different circum- Whittier and Freeman have found that high Mg intake in
stances in different tissue, vitamin D-intoxicated rats increased the degree of soft
The Ca/Mg/P molar ratio of visceral calcification was tissue calcification, and these authors suggest the formation
constant in 33 tissue specimens obtained from 19 uremic of some unkonwn Ca/Mg/P compound [23].
patients and decidedly different from the ratio of these In contrast to skin calcification, which has been shown
three ions found in nonvisceral calcification. The diffraction to be related to hyperparathyroidism [24], such a relation-
pattern in all untreated tissues with visceral calcification ship was not found to exist with regard to visceral (heart,
showed the low, broad pattern of either an amorphous lung and muscle) calcification. Since diffraction studies
compound or a substance having a very small crystal size, have not been performed on skin calcification, it is possible
This difference in crystal size between visceral and non- that it represents a different crystalline structure.
visceral calcification might explain the differences in tissue Although pulmonary and myocardial calcification can
response evoked by these two compounds. lead to disability and death, the diagnosis is frequently
In an attempt to further characterize visceral and non- difficult to make before death. The finding in this study of
visceral calcification, diffraction was performed following an excellent correlation between elevated skeletal muscle
incineration at 500 and 900° C. Heating results in improved Ca content and pulmonary and myocardial calcification
diffraction patterns as a result of dehydration and fusion suggests that muscle analysis may be useful in diagnosing
of cell units. High temperatures cause diffusion of ions in this complication. The demonstration of normal muscle
a solid state and may lead to transformation. Carlström Ca concentration prior to transplantation might be espe-
states that the compound resulting from heat transforma- cially useful in excluding cardiac and pulmonary calcifica-
tion is dependent upon the Ca/P ratio [12]. tion in selected patients suspected of having this com-
As would be expected, incineration of nonvisceral calci- plication.
fication at 900° C resulted only in sharpening of the apatite Nonvisceral calcification (hydroxyapatite) has been
peaks [12]. Infrared studies have further documented that found to be preventable by reducing serum P concentration
nonvisceral calcification is a carbonate-containing apatite. and in turn the Ca x P product [5]. Using dialysis and
However, with incineration the amorphous pattern of phosphate binding gels, we have been able to prevent the
visceral calcification was transformed into that of magne- development of nonvisceral calcification in our dialysis
sium whitlockite. The molar ratio of visceral calcification population. However, as is apparent from the present
and heat transformation to whitlockite would make it most study, visceral calcification continues to occur. It is Un-
unlikely that this amorphous compound is either secondary known whether further lowering of serum P would prevent
calcium phosphate [13] or hydroxyapatite [9]. Furthermore, the formation of visceral calcification. Since Mg also is a
recent studies carried out by the authors employing syn- major constituent of this compound, it seems possible that
thetic Ca/Mg/P compounds suggest that visceral calcifica- lowering serum Mg concentration might also be useful in
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preventing this complication. Additional studies are re-
quired to determine if, once present, visceral calcification
can be mobilized from the involved organs by lowering the
Ca/Mg/P product as previously described for nonvisceral
calcification [25]. A study of serial muscle biopsy specimens
might be useful in determining response to various thera-
peutic maneuvers.
Acknowledgments
This study was supported in part by Veterans Administia-
tion research grant 0233.02 and by U.S. Public Health
Service grant RR-51 from the General Clinical Research
program of the Division of Research Resources, National
Institutes of Health. Ms. Dottie Goodman provided secre-
tarial assistance.
Reprint requests to Dr. Allen C. Aifrey, Veterans Administra-
tion Hospital, 1055 Clermont Street, Denver, Colorado 80220,
U.S.A.
References
1. MULLIGAN RM: Metastatic calcification. Arch Pathol
43:177—230, 1947
2. MASSRY SG, POPOVTZER MM, COBURN JW, MAK0FF DL,
MAXWELL. MH, KLEMAN CR: Intractable pruritis as a mani-
festation of secondary hyperparathyroidism in uremia. N
Engl J Med 279:697—701, 1968
3. BONER G, JACOB ET, PERZNER S, JUNGMANN A: Diffuse cal-
cification of lungs in a patient on maintainence hemodialysis.
IsrJMedScil:1182—1187, 1971
4. TERMAN DS, ALFREY AC, HAMMOND WS, DONNDELINGER T,
OGDEN DA, HOLMES JH: Cardiac calcification in uremia.
Am J Med 50:744—755, 1971
5. CANER, JE, DECKER JL: Recurrent acute (?gouty) arthritis
in chronic renal failure treated with periodic hemodialysis.
Am J Med 36:571—582, 1964
6. MASSRY SG, COBURN J, PoPovrzER MM: Secondary hyper-
parathyroidism in chronic renal failure: The chemical spec-
trum in uremia, during hemodialysis and after transplanta-
tion. Arch Intern Med 124:431—441, 1969
7. PARFITT MA: Soft tissue calcification in uremia. Arch Intern
Med 124:544—556, 1969
8. FISKE CH, SUBBAROW Y: Phosphocreatinine. J Biol Chem
81:629—652, 1929
9. LEGER05 RZ, LEGEROS JP, TRAUTZ OR, KLEIN E: Spectral
properties of CO3 in C03-containing apatites. Dev App! Spec
7B:3—11, 1970
10. LEGERO5 RZ, LEGEROS JP, SHIRRA WP: Comparative crys-
tallinity and morphology of enamel, dentine, bone and
amorphous concretions (abstract), 28th Annual Proceedings
of the Electron Microscopic Society of America, 1970
11. CARLSTROM D, ENGFELDT B, ENGSTROM A, RINGERTZ N:
Studies on the chemical composition of normal and ab-
normal blood vessel walls: I. Chemical nature of calcified
deposits. Lab Invest 2 :325—335, 1953
12. CARLSTROM D: X-ray crystallographic studies on apatites
and calcified structures. Acta Radio! [Diag] [Suppl]
(Stock/i) 121, 1955
13. HIRSCHMAN A, SOBEL AF, KRAMER B, FANKUCHEN I: x-ray
diffraction study of high phosphate bones. J Biol Chem
171:285—291, 1947
14. LEGEROS RZ, CONTIGUGLIA SR, ALFREY AC: Evidence for
two types of calcium phosphate deposits in uremia (un-
published observations)
15. FRONDEL C: Whitlockite: A new calcium phosphate,
Ca3(P04)2. Am Mineral 26:145—152, 1941
16. TRAUTZ OR, LEGEROS RZ: Effect of magnesium on various
calcium phosphates I (abstract). 40th General Meeting of
the IADR 101, 1962
17. TRAUTZ OR, LEGEROS RZ, LEGERO5 JP: Effect of magne-
sium on calcium phosphates II. J Dent Res 43:17, 1964
18. RowLEs SL: Precipitation of whitlockite from aqueous solu-
tions. Bull Soc Chim Fr, Spec No., pp 1797—1802, 1968
19. LEGERO5 RZ, MORALES P: Renal stone crystals in gel sys-
tems: A preliminary report. Research Forum of the
American Urological Association, Washington, DC, May
21—25, 1972
20. LEGEROS RZ, TRAUTZ OR, LEGEROS JP, et al: Pyrolysis of
biological apatites: X-ray diffraction and infrared absorp-
tion studies (abstract). 48th Gen Meeting IADR 171, 1970
21. GATTER RA, MCCARTY OJ: Pathological tissue calcification
in man. Arch Patho! 84: 346—353, 1967
22. CONTIGUGLIA SR. ALFREY AC, MILLER N, BuTKUS D: Total-
body magnesium excess in chronic renal failure. Lancet
1:1300—1302, 1972
23. WHIrrIER F, FREEMAN R: Potentiation of metastatic calcifi-
cation in vitamin-D-treated rats by magnesium. Am J
Physiol 220:209—212, 1971
24. MASSRY 5, COBURN I, HORTENBOWER D, SHINABERGER JH,
DEPALMA GR, CHAPMAN E, KLEEMAN CR: The effect of
calcemic disorders and uremia on the mineral content of
skin. IsrfMedScil:514—517, 1971
25. ALFREY AC, JENKINS D, GROTH CG, SCHORR WS, GECELTER
L, OGDEN DA: Resolution of hyperparathyroidism, renal
osteodystrophy and metastatic calcification after renal
homotransplantation. NEng! J Med 279:1349—1356, 1968
